A Study to Assess the Efficacy and Safety of Solriamfetol in Adolescents With ADHD
Clinical trial NCT07717892 · RECRUITING
Trial details
- NCT number
- NCT07717892
- Sponsor
- Axsome Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-25
- Primary completion
- 2028-06-30
- Enrollment
- 468
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.